| NCT Number | NCT06483373 |
| Lead Sponsor | Shanghai Pharmaceuticals Holding Co., Ltd |
| Conditions | Inflammatory Bowel Disease |
| Enrollment | 111 participants |
| Start Date | 2024-05-28 |
| Primary Completion | 2026-12-31 (estimated) |
| Study Completion | 2026-12-31 (estimated) |
| Updated on ClinicalTrials.gov | 2026-05-05 |